CDC revises guidance on controlling C. auris in hospitals

Candida auris is an emerging, multidrug-resistant yeast that is poised to spread quickly through healthcare settings if not contained. The CDC originally issued recommendations for hospitals to prevent C. auris infections in June 2016, and updated the recommendations earlier this month.

Advertisement

The new recommendations include tips for how to treat invasive C. auris infections and what infection control measures to use for patients who have an infection or are colonized with C. auris.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox

According to the U.S. Environmental Protection Agency, one of the main changes in the new CDC recommendations is to clean rooms of patients with C. auris daily and post-discharge with an EPA-registered disinfectant that is effective against Clostridium difficile. Previously, the CDC recommended using disinfectants effective against fungi.

Find a list of EPA-registered disinfectants effective against C. diff spores here.

See the full recommendations from the CDC on C. auris here.

More articles on infection prevention:
4 things to know about the infection prevention profession
CDC: 13 people affected by rare rat virus outbreak
Rare, deadly strep bacteria continues to spread in Alaska’s homeless population

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.